nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—TUBB4B—Docetaxel—melanoma	0.223	0.367	CbGbCtD
Albendazole—ABCB1—melanoma	0.215	1	CbGaD
Albendazole—CYP1A1—Dacarbazine—melanoma	0.0909	0.149	CbGbCtD
Albendazole—CYP1A2—Carmustine—melanoma	0.067	0.11	CbGbCtD
Albendazole—CYP1A2—Vemurafenib—melanoma	0.053	0.0869	CbGbCtD
Albendazole—CYP3A4—Temozolomide—melanoma	0.0507	0.0831	CbGbCtD
Albendazole—CYP1A2—Dacarbazine—melanoma	0.0406	0.0666	CbGbCtD
Albendazole—ABCB1—Dactinomycin—melanoma	0.0308	0.0505	CbGbCtD
Albendazole—CYP3A4—Vemurafenib—melanoma	0.0278	0.0456	CbGbCtD
Albendazole—ABCB1—Docetaxel—melanoma	0.0159	0.0261	CbGbCtD
Albendazole—TUBA1A—optic choroid—melanoma	0.0104	0.224	CbGeAlD
Albendazole—CYP3A4—Docetaxel—melanoma	0.00952	0.0156	CbGbCtD
Albendazole—TUBA1A—hair follicle—melanoma	0.00421	0.0905	CbGeAlD
Albendazole—TUBB4B—skin epidermis—melanoma	0.00393	0.0845	CbGeAlD
Albendazole—TUBA1A—neck—melanoma	0.00282	0.0607	CbGeAlD
Albendazole—Intracranial pressure increased—Carmustine—melanoma	0.00281	0.0534	CcSEcCtD
Albendazole—TUBB4B—hair follicle—melanoma	0.0028	0.0603	CbGeAlD
Albendazole—CYP1A1—skin epidermis—melanoma	0.0022	0.0473	CbGeAlD
Albendazole—TUBA1A—eye—melanoma	0.0021	0.0451	CbGeAlD
Albendazole—TUBA1A—retina—melanoma	0.00208	0.0447	CbGeAlD
Albendazole—TUBA1A—skin of body—melanoma	0.00183	0.0393	CbGeAlD
Albendazole—TUBA1A—mammalian vulva—melanoma	0.00167	0.0358	CbGeAlD
Albendazole—TUBB4B—eye—melanoma	0.0014	0.0301	CbGeAlD
Albendazole—TUBB4B—retina—melanoma	0.00139	0.0298	CbGeAlD
Albendazole—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00123	0.0234	CcSEcCtD
Albendazole—TUBB4B—skin of body—melanoma	0.00122	0.0262	CbGeAlD
Albendazole—TUBA1A—head—melanoma	0.00119	0.0256	CbGeAlD
Albendazole—Aplastic anaemia—Dactinomycin—melanoma	0.00118	0.0224	CcSEcCtD
Albendazole—TUBB4B—mammalian vulva—melanoma	0.00111	0.0239	CbGeAlD
Albendazole—Aplastic anaemia—Temozolomide—melanoma	0.00106	0.0202	CcSEcCtD
Albendazole—Erythema multiforme—Vemurafenib—melanoma	0.00105	0.02	CcSEcCtD
Albendazole—Alopecia—Vemurafenib—melanoma	0.000984	0.0187	CcSEcCtD
Albendazole—Liver function test abnormal—Dactinomycin—melanoma	0.000839	0.016	CcSEcCtD
Albendazole—TUBA1A—lymph node—melanoma	0.000835	0.0179	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000819	0.0156	CcSEcCtD
Albendazole—Pancytopenia—Bleomycin—melanoma	0.0008	0.0152	CcSEcCtD
Albendazole—TUBB4B—head—melanoma	0.000795	0.0171	CbGeAlD
Albendazole—Liver function test abnormal—Carmustine—melanoma	0.000786	0.0149	CcSEcCtD
Albendazole—Skin disorder—Vemurafenib—melanoma	0.000768	0.0146	CcSEcCtD
Albendazole—ABCB1—blood vessel—melanoma	0.000765	0.0164	CbGeAlD
Albendazole—Pancytopenia—Dactinomycin—melanoma	0.000746	0.0142	CcSEcCtD
Albendazole—Neutropenia—Dactinomycin—melanoma	0.000735	0.014	CcSEcCtD
Albendazole—Pancytopenia—Carmustine—melanoma	0.000698	0.0133	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000695	0.0132	CcSEcCtD
Albendazole—Neutropenia—Carmustine—melanoma	0.000688	0.0131	CcSEcCtD
Albendazole—CYP1A1—skin of body—melanoma	0.000682	0.0147	CbGeAlD
Albendazole—Pancytopenia—Temozolomide—melanoma	0.000675	0.0128	CcSEcCtD
Albendazole—Neutropenia—Temozolomide—melanoma	0.000665	0.0126	CcSEcCtD
Albendazole—Agranulocytosis—Dactinomycin—melanoma	0.000654	0.0124	CcSEcCtD
Albendazole—Hepatitis—Dactinomycin—melanoma	0.000629	0.012	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000628	0.0119	CcSEcCtD
Albendazole—Body temperature increased—Vemurafenib—melanoma	0.000625	0.0119	CcSEcCtD
Albendazole—CYP1A1—mammalian vulva—melanoma	0.000622	0.0134	CbGeAlD
Albendazole—Hepatobiliary disease—Temozolomide—melanoma	0.000599	0.0114	CcSEcCtD
Albendazole—Alopecia—Bleomycin—melanoma	0.000596	0.0113	CcSEcCtD
Albendazole—Erythema multiforme—Dactinomycin—melanoma	0.000595	0.0113	CcSEcCtD
Albendazole—Hypersensitivity—Vemurafenib—melanoma	0.000583	0.0111	CcSEcCtD
Albendazole—Hepatitis—Temozolomide—melanoma	0.000569	0.0108	CcSEcCtD
Albendazole—Urinary tract disorder—Temozolomide—melanoma	0.000562	0.0107	CcSEcCtD
Albendazole—Urethral disorder—Temozolomide—melanoma	0.000558	0.0106	CcSEcCtD
Albendazole—TUBB4B—lymph node—melanoma	0.000556	0.012	CbGeAlD
Albendazole—Alopecia—Dactinomycin—melanoma	0.000556	0.0106	CcSEcCtD
Albendazole—Erythema multiforme—Temozolomide—melanoma	0.000538	0.0102	CcSEcCtD
Albendazole—Leukopenia—Bleomycin—melanoma	0.000526	0.00999	CcSEcCtD
Albendazole—Dizziness—Vemurafenib—melanoma	0.000523	0.00994	CcSEcCtD
Albendazole—Alopecia—Carmustine—melanoma	0.00052	0.00989	CcSEcCtD
Albendazole—Immune system disorder—Temozolomide—melanoma	0.000514	0.00977	CcSEcCtD
Albendazole—Liver function test abnormal—Docetaxel—melanoma	0.000505	0.0096	CcSEcCtD
Albendazole—Vomiting—Vemurafenib—melanoma	0.000503	0.00956	CcSEcCtD
Albendazole—Alopecia—Temozolomide—melanoma	0.000503	0.00956	CcSEcCtD
Albendazole—Rash—Vemurafenib—melanoma	0.000499	0.00948	CcSEcCtD
Albendazole—Dermatitis—Vemurafenib—melanoma	0.000498	0.00947	CcSEcCtD
Albendazole—Headache—Vemurafenib—melanoma	0.000495	0.00942	CcSEcCtD
Albendazole—Leukopenia—Dactinomycin—melanoma	0.00049	0.00932	CcSEcCtD
Albendazole—Nausea—Vemurafenib—melanoma	0.00047	0.00893	CcSEcCtD
Albendazole—Thrombocytopenia—Bleomycin—melanoma	0.000469	0.00892	CcSEcCtD
Albendazole—Leukopenia—Carmustine—melanoma	0.000459	0.00872	CcSEcCtD
Albendazole—Pancytopenia—Docetaxel—melanoma	0.000449	0.00854	CcSEcCtD
Albendazole—Vertigo—Temozolomide—melanoma	0.000445	0.00846	CcSEcCtD
Albendazole—CYP1A1—head—melanoma	0.000445	0.00956	CbGeAlD
Albendazole—Leukopenia—Temozolomide—melanoma	0.000443	0.00843	CcSEcCtD
Albendazole—Neutropenia—Docetaxel—melanoma	0.000442	0.0084	CcSEcCtD
Albendazole—Thrombocytopenia—Dactinomycin—melanoma	0.000438	0.00832	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000419	0.00796	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000418	0.00794	CcSEcCtD
Albendazole—Thrombocytopenia—Carmustine—melanoma	0.00041	0.00779	CcSEcCtD
Albendazole—ABCB1—retina—melanoma	0.000403	0.00867	CbGeAlD
Albendazole—Hepatobiliary disease—Docetaxel—melanoma	0.000399	0.00758	CcSEcCtD
Albendazole—Thrombocytopenia—Temozolomide—melanoma	0.000396	0.00752	CcSEcCtD
Albendazole—Agranulocytosis—Docetaxel—melanoma	0.000393	0.00748	CcSEcCtD
Albendazole—Skin disorder—Temozolomide—melanoma	0.000393	0.00747	CcSEcCtD
Albendazole—Urticaria—Bleomycin—melanoma	0.000381	0.00724	CcSEcCtD
Albendazole—Body temperature increased—Bleomycin—melanoma	0.000379	0.0072	CcSEcCtD
Albendazole—Hepatitis—Docetaxel—melanoma	0.000378	0.00719	CcSEcCtD
Albendazole—Urinary tract disorder—Docetaxel—melanoma	0.000374	0.0071	CcSEcCtD
Albendazole—Urethral disorder—Docetaxel—melanoma	0.000371	0.00705	CcSEcCtD
Albendazole—Gastrointestinal pain—Dactinomycin—melanoma	0.000365	0.00695	CcSEcCtD
Albendazole—Erythema multiforme—Docetaxel—melanoma	0.000358	0.0068	CcSEcCtD
Albendazole—Abdominal pain—Dactinomycin—melanoma	0.000353	0.00672	CcSEcCtD
Albendazole—Body temperature increased—Dactinomycin—melanoma	0.000353	0.00672	CcSEcCtD
Albendazole—Hypersensitivity—Bleomycin—melanoma	0.000353	0.00671	CcSEcCtD
Albendazole—Gastrointestinal pain—Carmustine—melanoma	0.000342	0.0065	CcSEcCtD
Albendazole—Immune system disorder—Docetaxel—melanoma	0.000342	0.0065	CcSEcCtD
Albendazole—Alopecia—Docetaxel—melanoma	0.000334	0.00636	CcSEcCtD
Albendazole—Abdominal pain—Carmustine—melanoma	0.000331	0.00629	CcSEcCtD
Albendazole—Body temperature increased—Carmustine—melanoma	0.000331	0.00629	CcSEcCtD
Albendazole—Gastrointestinal pain—Temozolomide—melanoma	0.000331	0.00628	CcSEcCtD
Albendazole—Hypersensitivity—Dactinomycin—melanoma	0.000329	0.00626	CcSEcCtD
Albendazole—ABCB1—mammalian vulva—melanoma	0.000323	0.00694	CbGeAlD
Albendazole—Urticaria—Temozolomide—melanoma	0.000321	0.00611	CcSEcCtD
Albendazole—Abdominal pain—Temozolomide—melanoma	0.00032	0.00608	CcSEcCtD
Albendazole—Body temperature increased—Temozolomide—melanoma	0.00032	0.00608	CcSEcCtD
Albendazole—CYP1A1—lymph node—melanoma	0.000312	0.0067	CbGeAlD
Albendazole—Hypersensitivity—Carmustine—melanoma	0.000308	0.00586	CcSEcCtD
Albendazole—Vomiting—Bleomycin—melanoma	0.000305	0.00579	CcSEcCtD
Albendazole—Rash—Bleomycin—melanoma	0.000302	0.00574	CcSEcCtD
Albendazole—Dermatitis—Bleomycin—melanoma	0.000302	0.00574	CcSEcCtD
Albendazole—Hypersensitivity—Temozolomide—melanoma	0.000298	0.00566	CcSEcCtD
Albendazole—Leukopenia—Docetaxel—melanoma	0.000295	0.00561	CcSEcCtD
Albendazole—Nausea—Bleomycin—melanoma	0.000285	0.00541	CcSEcCtD
Albendazole—Vomiting—Dactinomycin—melanoma	0.000284	0.0054	CcSEcCtD
Albendazole—Rash—Dactinomycin—melanoma	0.000282	0.00536	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000278	0.00529	CcSEcCtD
Albendazole—Dizziness—Carmustine—melanoma	0.000277	0.00526	CcSEcCtD
Albendazole—Dizziness—Temozolomide—melanoma	0.000267	0.00508	CcSEcCtD
Albendazole—Vomiting—Carmustine—melanoma	0.000266	0.00506	CcSEcCtD
Albendazole—Nausea—Dactinomycin—melanoma	0.000265	0.00505	CcSEcCtD
Albendazole—Rash—Carmustine—melanoma	0.000264	0.00501	CcSEcCtD
Albendazole—Dermatitis—Carmustine—melanoma	0.000263	0.00501	CcSEcCtD
Albendazole—Thrombocytopenia—Docetaxel—melanoma	0.000263	0.005	CcSEcCtD
Albendazole—Headache—Carmustine—melanoma	0.000262	0.00498	CcSEcCtD
Albendazole—Skin disorder—Docetaxel—melanoma	0.000261	0.00496	CcSEcCtD
Albendazole—Vomiting—Temozolomide—melanoma	0.000257	0.00489	CcSEcCtD
Albendazole—Rash—Temozolomide—melanoma	0.000255	0.00485	CcSEcCtD
Albendazole—Dermatitis—Temozolomide—melanoma	0.000255	0.00484	CcSEcCtD
Albendazole—Headache—Temozolomide—melanoma	0.000253	0.00481	CcSEcCtD
Albendazole—Nausea—Carmustine—melanoma	0.000248	0.00472	CcSEcCtD
Albendazole—Nausea—Temozolomide—melanoma	0.00024	0.00457	CcSEcCtD
Albendazole—ABCB1—head—melanoma	0.000231	0.00497	CbGeAlD
Albendazole—Gastrointestinal pain—Docetaxel—melanoma	0.00022	0.00418	CcSEcCtD
Albendazole—Abdominal pain—Docetaxel—melanoma	0.000212	0.00404	CcSEcCtD
Albendazole—Body temperature increased—Docetaxel—melanoma	0.000212	0.00404	CcSEcCtD
Albendazole—Hypersensitivity—Docetaxel—melanoma	0.000198	0.00377	CcSEcCtD
Albendazole—Dizziness—Docetaxel—melanoma	0.000178	0.00338	CcSEcCtD
Albendazole—Vomiting—Docetaxel—melanoma	0.000171	0.00325	CcSEcCtD
Albendazole—Rash—Docetaxel—melanoma	0.000169	0.00322	CcSEcCtD
Albendazole—Dermatitis—Docetaxel—melanoma	0.000169	0.00322	CcSEcCtD
Albendazole—Headache—Docetaxel—melanoma	0.000168	0.0032	CcSEcCtD
Albendazole—ABCB1—lymph node—melanoma	0.000162	0.00348	CbGeAlD
Albendazole—Nausea—Docetaxel—melanoma	0.00016	0.00304	CcSEcCtD
Albendazole—TUBB4B—Metabolism of proteins—MMP1—melanoma	3.85e-05	0.000503	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	3.8e-05	0.000497	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	3.8e-05	0.000497	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	3.8e-05	0.000497	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.79e-05	0.000496	CbGpPWpGaD
Albendazole—TUBA1A—Metabolism of proteins—CTNNB1—melanoma	3.78e-05	0.000494	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MAPK3—melanoma	3.77e-05	0.000494	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	3.77e-05	0.000493	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	3.75e-05	0.000491	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.74e-05	0.00049	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—RB1—melanoma	3.72e-05	0.000487	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	3.69e-05	0.000482	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HS3ST5—melanoma	3.68e-05	0.000481	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MYC—melanoma	3.67e-05	0.00048	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—melanoma	3.66e-05	0.000479	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	3.65e-05	0.000477	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	3.61e-05	0.000473	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	3.61e-05	0.000473	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	3.61e-05	0.000473	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—MAPK1—melanoma	3.59e-05	0.00047	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	3.59e-05	0.000469	CbGpPWpGaD
Albendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—melanoma	3.58e-05	0.000469	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	3.54e-05	0.000463	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	3.48e-05	0.000455	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ACER3—melanoma	3.45e-05	0.000452	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—VEGFA—melanoma	3.43e-05	0.000449	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	3.41e-05	0.000447	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	3.35e-05	0.000438	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN2A—melanoma	3.27e-05	0.000428	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—melanoma	3.24e-05	0.000424	CbGpPWpGaD
Albendazole—TUBB4B—Transmembrane transport of small molecules—ALB—melanoma	3.21e-05	0.00042	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.19e-05	0.000418	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	3.18e-05	0.000416	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MDM2—melanoma	3.17e-05	0.000415	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—UGT2B10—melanoma	3.16e-05	0.000413	CbGpPWpGaD
Albendazole—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.15e-05	0.000412	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.13e-05	0.00041	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—melanoma	3.09e-05	0.000405	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—IGF1—melanoma	3.08e-05	0.000402	CbGpPWpGaD
Albendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	3.05e-05	0.000399	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	3.02e-05	0.000395	CbGpPWpGaD
Albendazole—TUBA1A—Cell Cycle—TP53—melanoma	3.02e-05	0.000395	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	3e-05	0.000393	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—melanoma	2.99e-05	0.000391	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—MMP2—melanoma	2.98e-05	0.000389	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.96e-05	0.000387	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—melanoma	2.94e-05	0.000384	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HS3ST5—melanoma	2.94e-05	0.000384	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.93e-05	0.000383	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN1B—melanoma	2.9e-05	0.000379	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	2.83e-05	0.00037	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	2.8e-05	0.000366	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PLCB4—melanoma	2.79e-05	0.000365	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CCND1—melanoma	2.76e-05	0.000362	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ACER3—melanoma	2.76e-05	0.000361	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—FASN—melanoma	2.74e-05	0.000358	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—CDKN1A—melanoma	2.67e-05	0.00035	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.63e-05	0.000345	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIP4K2A—melanoma	2.62e-05	0.000343	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC6A11—melanoma	2.62e-05	0.000343	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2.59e-05	0.000339	CbGpPWpGaD
Albendazole—Mebendazole—ABCB1—melanoma	2.58e-05	1	CrCbGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MAPK3—melanoma	2.55e-05	0.000334	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTAP—melanoma	2.55e-05	0.000334	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	2.53e-05	0.00033	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UGT2B10—melanoma	2.52e-05	0.00033	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	2.5e-05	0.000328	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.49e-05	0.000326	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.49e-05	0.000326	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MYC—melanoma	2.48e-05	0.000324	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CXCL8—melanoma	2.47e-05	0.000324	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle, Mitotic—MAPK1—melanoma	2.43e-05	0.000317	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.38e-05	0.000312	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HS3ST5—melanoma	2.34e-05	0.000307	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CTNNB1—melanoma	2.28e-05	0.000299	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MAPK3—melanoma	2.28e-05	0.000298	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PHGDH—melanoma	2.27e-05	0.000297	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LUM—melanoma	2.27e-05	0.000297	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.26e-05	0.000296	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HPSE—melanoma	2.23e-05	0.000292	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.23e-05	0.000292	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLCB4—melanoma	2.23e-05	0.000291	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MYC—melanoma	2.22e-05	0.00029	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.2e-05	0.000287	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CUBN—melanoma	2.19e-05	0.000286	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—MAPK1—melanoma	2.17e-05	0.000284	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.15e-05	0.000281	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ACER3—melanoma	2.13e-05	0.000278	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BSG—melanoma	2.11e-05	0.000276	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CSPG4—melanoma	2.11e-05	0.000276	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SDHD—melanoma	2.11e-05	0.000276	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC6A11—melanoma	2.09e-05	0.000274	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIP4K2A—melanoma	2.09e-05	0.000274	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPAM—melanoma	2.05e-05	0.000268	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.04e-05	0.000267	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTAP—melanoma	2.04e-05	0.000266	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.03e-05	0.000266	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.99e-05	0.000261	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UGT2B10—melanoma	1.95e-05	0.000255	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.94e-05	0.000254	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.92e-05	0.000251	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.89e-05	0.000247	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.88e-05	0.000246	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.87e-05	0.000245	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.86e-05	0.000244	CbGpPWpGaD
Albendazole—TUBB4B—Cell Cycle—TP53—melanoma	1.82e-05	0.000238	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PHGDH—melanoma	1.81e-05	0.000237	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LUM—melanoma	1.81e-05	0.000237	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HS3ST5—melanoma	1.81e-05	0.000237	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HPSE—melanoma	1.78e-05	0.000233	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLCB4—melanoma	1.78e-05	0.000233	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CUBN—melanoma	1.75e-05	0.000229	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.74e-05	0.000228	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PLA2G6—melanoma	1.74e-05	0.000228	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.69e-05	0.000221	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SDHD—melanoma	1.69e-05	0.000221	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BSG—melanoma	1.69e-05	0.000221	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CSPG4—melanoma	1.69e-05	0.000221	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC6A11—melanoma	1.67e-05	0.000219	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIP4K2A—melanoma	1.67e-05	0.000219	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPAM—melanoma	1.63e-05	0.000214	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTAP—melanoma	1.63e-05	0.000213	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.6e-05	0.000209	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.59e-05	0.000208	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—VCAN—melanoma	1.56e-05	0.000204	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.56e-05	0.000204	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.52e-05	0.000199	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.52e-05	0.000199	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.48e-05	0.000194	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.45e-05	0.00019	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PHGDH—melanoma	1.45e-05	0.00019	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LUM—melanoma	1.45e-05	0.00019	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.44e-05	0.000188	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.43e-05	0.000187	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HPSE—melanoma	1.42e-05	0.000186	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CUBN—melanoma	1.39e-05	0.000182	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLA2G6—melanoma	1.39e-05	0.000182	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLCB4—melanoma	1.37e-05	0.000179	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SDHD—melanoma	1.35e-05	0.000176	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BSG—melanoma	1.35e-05	0.000176	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CSPG4—melanoma	1.35e-05	0.000176	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.32e-05	0.000173	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP17A1—melanoma	1.32e-05	0.000172	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPAM—melanoma	1.3e-05	0.000171	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.3e-05	0.00017	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIP4K2A—melanoma	1.29e-05	0.000169	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC6A11—melanoma	1.29e-05	0.000169	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.28e-05	0.000168	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.28e-05	0.000167	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTAP—melanoma	1.25e-05	0.000164	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—VCAN—melanoma	1.25e-05	0.000163	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GNA11—melanoma	1.24e-05	0.000163	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—FASN—melanoma	1.22e-05	0.000159	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC5A5—melanoma	1.2e-05	0.000157	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CD44—melanoma	1.16e-05	0.000151	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GNAQ—melanoma	1.16e-05	0.000151	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.13e-05	0.000148	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.12e-05	0.000147	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LUM—melanoma	1.12e-05	0.000146	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PHGDH—melanoma	1.12e-05	0.000146	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP1B1—melanoma	1.11e-05	0.000145	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLA2G6—melanoma	1.11e-05	0.000145	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HPSE—melanoma	1.1e-05	0.000143	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.08e-05	0.000141	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CUBN—melanoma	1.08e-05	0.000141	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP17A1—melanoma	1.05e-05	0.000138	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CSPG4—melanoma	1.04e-05	0.000136	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SDHD—melanoma	1.04e-05	0.000136	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BSG—melanoma	1.04e-05	0.000136	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPAM—melanoma	1.01e-05	0.000132	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—VCAN—melanoma	9.96e-06	0.00013	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GNA11—melanoma	9.94e-06	0.00013	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.79e-06	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.75e-06	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—FASN—melanoma	9.73e-06	0.000127	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC5A5—melanoma	9.57e-06	0.000125	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.43e-06	0.000123	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GNAQ—melanoma	9.24e-06	0.000121	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CD44—melanoma	9.24e-06	0.000121	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—melanoma	9.14e-06	0.00012	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.1e-06	0.000119	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1B1—melanoma	8.86e-06	0.000116	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLA2G6—melanoma	8.56e-06	0.000112	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PRKCA—melanoma	8.41e-06	0.00011	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP17A1—melanoma	8.4e-06	0.00011	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ERCC2—melanoma	8.34e-06	0.000109	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.29e-06	0.000108	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.18e-06	0.000107	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GNA11—melanoma	7.94e-06	0.000104	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—FASN—melanoma	7.77e-06	0.000102	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—VCAN—melanoma	7.69e-06	0.000101	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC5A5—melanoma	7.64e-06	0.0001	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GNAQ—melanoma	7.38e-06	9.66e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CD44—melanoma	7.38e-06	9.66e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.23e-06	9.45e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.16e-06	9.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP1B1—melanoma	7.07e-06	9.26e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.91e-06	9.04e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PRKCA—melanoma	6.72e-06	8.79e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ERCC2—melanoma	6.66e-06	8.72e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CG—melanoma	6.59e-06	8.62e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP17A1—melanoma	6.49e-06	8.49e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—melanoma	6.36e-06	8.32e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.24e-06	8.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GNA11—melanoma	6.13e-06	8.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FASN—melanoma	5.99e-06	7.84e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC5A5—melanoma	5.9e-06	7.72e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—melanoma	5.83e-06	7.62e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CD—melanoma	5.79e-06	7.58e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—melanoma	5.72e-06	7.48e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GNAQ—melanoma	5.69e-06	7.45e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CD44—melanoma	5.69e-06	7.45e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1B1—melanoma	5.46e-06	7.14e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PRKCA—melanoma	5.36e-06	7.02e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ERCC2—melanoma	5.32e-06	6.96e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CG—melanoma	5.26e-06	6.88e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—melanoma	5.08e-06	6.64e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CB—melanoma	5.05e-06	6.6e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—melanoma	5e-06	6.54e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CD—melanoma	4.62e-06	6.05e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—melanoma	4.56e-06	5.97e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—melanoma	4.5e-06	5.88e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.4e-06	5.76e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTEN—melanoma	4.36e-06	5.71e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CG—melanoma	4.2e-06	5.5e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PRKCA—melanoma	4.14e-06	5.41e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ERCC2—melanoma	4.1e-06	5.37e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—melanoma	4.05e-06	5.3e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CB—melanoma	4.03e-06	5.27e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—melanoma	3.99e-06	5.23e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CD—melanoma	3.69e-06	4.83e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—melanoma	3.64e-06	4.77e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTEN—melanoma	3.48e-06	4.56e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CG—melanoma	3.24e-06	4.24e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CB—melanoma	3.22e-06	4.21e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—melanoma	3.19e-06	4.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—melanoma	3.13e-06	4.09e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3CA—melanoma	3.08e-06	4.03e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CD—melanoma	2.85e-06	3.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—melanoma	2.81e-06	3.68e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTEN—melanoma	2.78e-06	3.64e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—melanoma	2.51e-06	3.29e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CB—melanoma	2.48e-06	3.25e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—melanoma	2.46e-06	3.22e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3CA—melanoma	2.46e-06	3.22e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTEN—melanoma	2.15e-06	2.81e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—melanoma	2.01e-06	2.63e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3CA—melanoma	1.96e-06	2.57e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—melanoma	1.6e-06	2.1e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3CA—melanoma	1.51e-06	1.98e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—melanoma	1.24e-06	1.62e-05	CbGpPWpGaD
